MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo

Significance Vitiligo is a classic autoimmune disease genetically associated with SNPs in the MHC class II region. To date, the impact of HLA molecules on autoimmunity has focused on structural diversity of antigen presentation. Here, we describe the properties of a 47-nucleotide high-risk haplotype of three SNPs within an intergenic “super-enhancer” located between the HLA-DRB1 and HLA-DQA1 genes, localized by a genome-wide association study of 2,853 subjects with vitiligo. Monocytes from healthy subjects homozygous for the high-risk haplotype have increased surface expression of HLA-DR and -DQ, and peripheral blood mononuclear cells from high-risk subjects produce more IL-1β and IFN-γ upon engagement of dectin-1, mannose, and Toll-like receptors. This study underscores the importance of transcriptional regulation of HLA genes to the risk of developing an autoimmune disease. Genetic risk for autoimmunity in HLA genes is most often attributed to structural specificity resulting in presentation of self-antigens. Autoimmune vitiligo is strongly associated with the MHC class II region. Here, we fine-map vitiligo MHC class II genetic risk to three SNPs only 47 bp apart, located within a predicted super-enhancer in an intergenic region between HLA-DRB1 and HLA-DQA1, localized by a genome-wide association study of 2,853 Caucasian vitiligo patients. The super-enhancer corresponds to an expression quantitative trait locus for expression of HLA-DR and HLA-DQ RNA; we observed elevated surface expression of HLA-DR (P = 0.008) and HLA-DQ (P = 0.02) on monocytes from healthy subjects homozygous for the high-risk SNP haplotype. Unexpectedly, pathogen-stimulated peripheral blood mononuclear cells from subjects homozygous for the high-risk super-enhancer haplotype exhibited greater increase in production of IFN-γ and IL-1β than cells from subjects homozygous for the low-risk haplotype. Specifically, production of IFN-γ on stimulation of dectin-1, mannose, and Toll-like receptors with Candida albicans and Staphylococcus epidermidis was 2.5- and 2.9-fold higher in high-risk subjects than in low-risk subjects, respectively (P = 0.007 and P = 0.01). Similarly, production of IL-1β was fivefold higher in high-risk subjects than in low-risk subjects (P = 0.02). Increased production of immunostimulatory cytokines in subjects carrying the high-risk haplotype may act as an “adjuvant” during the presentation of autoantigens, tying together genetic variation in the MHC with the development of autoimmunity. This study demonstrates that for risk of autoimmune vitiligo, expression level of HLA class II molecules is as or more important than antigen specificity.

[1]  G. Cavalli,et al.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. , 2015, Rheumatology.

[2]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[3]  Effie W Petersdorf,et al.  High HLA-DP Expression and Graft-versus-Host Disease. , 2015, The New England journal of medicine.

[4]  G. Kempermann Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[5]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[6]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[7]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[8]  M. Carrington,et al.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. , 2014, Blood.

[9]  Han Xu,et al.  Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.

[10]  Morgan C. Giddings,et al.  Defining functional DNA elements in the human genome , 2014, Proceedings of the National Academy of Sciences.

[11]  A. Stark,et al.  Transcriptional enhancers: from properties to genome-wide predictions , 2014, Nature Reviews Genetics.

[12]  L. C. M. Ortigosa,et al.  Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report* , 2014, Anais brasileiros de dermatologia.

[13]  M. Leandro,et al.  Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab , 2013, Dermatologic therapy.

[14]  David Heckerman,et al.  Influence of HLA-C Expression Level on HIV Control , 2013, Science.

[15]  R. Spritz,et al.  NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome , 2013, Proceedings of the National Academy of Sciences.

[16]  William Stafford Noble,et al.  Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors , 2012, Genome research.

[17]  Xiao-hong Wang,et al.  Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. , 2012, World journal of gastroenterology.

[18]  M. Picardo,et al.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.

[19]  Jo Lambert,et al.  Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo , 2012, Nature Genetics.

[20]  Richard Apps,et al.  A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection , 2012, Journal of Virology.

[21]  K. Alghamdi,et al.  Treatment of generalized vitiligo with anti-TNF-α Agents. , 2012, Journal of drugs in dermatology : JDD.

[22]  A. Bosserhoff,et al.  Meeting report from the 2011 international melanoma congress, Tampa, Florida , 2012, Pigment cell & melanoma research.

[23]  E. Wherry,et al.  A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T cell accumulation in the skin , 2011, The Journal of investigative dermatology.

[24]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[25]  K. Alghamdi,et al.  Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab , 2011, Journal of cutaneous medicine and surgery.

[26]  Matthew W. Anderson,et al.  A multi-site study using high-resolution HLA genotyping by next generation sequencing. , 2011, Tissue antigens.

[27]  P. Majumder,et al.  DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture , 2010, Genes and Immunity.

[28]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[29]  Sheri L. Riccardi,et al.  Common variants in FOXP1 are associated with generalized vitiligo , 2010, Nature Genetics.

[30]  Jo Lambert,et al.  Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. , 2010, The New England journal of medicine.

[31]  R Higuchi,et al.  High-resolution, high-throughput HLA genotyping by next-generation sequencing. , 2009, Tissue antigens.

[32]  G. Hon,et al.  Predictive chromatin signatures in the mammalian genome. , 2009, Human molecular genetics.

[33]  A. Drosos,et al.  Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors , 2009, Scandinavian journal of rheumatology.

[34]  Jerzy K. Kulski,et al.  The HLA genomic loci map: expression, interaction, diversity and disease , 2009, Journal of Human Genetics.

[35]  Sue Povey,et al.  Gene map of the extended human MHC , 2004, Nature Reviews Genetics.

[36]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[37]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[38]  M. Netea,et al.  The Role of Endogenous Interleukin (IL)-18, IL-12, IL-1β, and Tumor Necrosis Factor-α in the Production of Interferon-γ Induced by Candida albicans in Human Whole-Blood Cultures , 2002 .

[39]  M. Netea,et al.  The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures. , 2002, The Journal of infectious diseases.

[40]  Philippa Marrack,et al.  Autoimmune disease: why and where it occurs , 2001, Nature Medicine.

[41]  B. Rocha,et al.  Peripheral T cell survival. , 1999, Current opinion in immunology.

[42]  H. Grey,et al.  The minimal number of antigen‐major histocompatibility complex class II complexes required for activation of naive and primed T cells , 1997, European journal of immunology.

[43]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[44]  M. Croft,et al.  A direct role for IFN-gamma in regulation of Th1 cell development. , 1996, Journal of immunology.

[45]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[46]  T. Espevik,et al.  Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha , 1987, The Journal of experimental medicine.